Injection Site Selection : Tirzepatide should be injected subcutaneously into the abdomen, thigh, or upper arm
Absolutely loving the results
I dont drink nearly as many energy drinks as I used to
The result: Increased lipolysis : Fat cells release stored fatty acids for use as fuel Inhibited lipogenesis : Dietary fats are less readily converted to stored body fat No significant IGF-1 stimulation : Means no growth of existing tumors or cancer risk amplification that concerns some clinicians with full GH No significant glucose disruption : Unlike full HGH, which causes insulin resistance at therapeutic doses, AOD-9604 shows minimal glucose impact in studies This makes it uniquely well-suited for fat loss use cases where full HGH would be too blunt an instrument
Participants who were given a higher dose of AOD-9604 (10 mg/day) did not lose more weight
Cycling AOD-9604: Duration, Breaks, and Receptor Sensitivity Typical AOD-9604 research protocols run 1224 weeks, mirroring the clinical trial durations that generated the primary efficacy data
